申请人:Fell Christopher Martin Stephen
公开号:US20050020832A1
公开(公告)日:2005-01-27
Compounds of the formula (I) are inhibitors of the enzyme Lp-PLA2 and are of use in therapy, in particular for treating atherosclerosis.
式(I)化合物是 Lp-PLA2 酶的抑制剂,可用于治疗,尤其是治疗动脉粥样硬化。